Ozempic, the blockbuster diabetes shot, is set for price negotiations with the US government under the Inflation Reduction Act, expected to affect its current price.
Ulrich Otte, a Novo Nordisk executive, indicated readiness for upcoming drug price negotiations, highlighting the drug's pivotal role in addressing diabetes management.
The US government now has authority to negotiate drug prices, similar to practices in other nations, which could significantly impact U.S. retail prescription costs.
CMS will announce new drug price negotiations and maximum fair prices, marking a significant shift in how drug pricing is managed across the United States.
Collection
[
|
...
]